Skip to main content
. 2023 Oct 19;89(1):72. doi: 10.5334/aogh.4009

Table 2.

Presenting diagnosis and indications for advanced respiratory support.


CHARACTERISTIC OVERALL INTUBATION NIPPV

N = 46 N = 27 (58.7%) N = 23 (50.0%)

Presumed diagnosis at time of respiratory supporta, n (%)

    Cardiovascular 16 (34.8%) 4 (14.8%) 13 (56.5%)

        Cardiogenic pulmonary edema 12 (26.1%) 1 (3.7%) 11 (47.8%)

        Cardiogenic shock 3 (6.5%) 0 (0.0%) 3 (13.0%)

        Pulmonary embolism 1 (2.2%) 0 (0.0%) 1 (4.3%)

        Hypovolemic shock 3 (6.5%) 3 (11.1%) 1 (4.3%)

        Hypertensive emergency 2 (4.3%) 0 (0.0%) 2 (8.7%)

    Respiratory 10 (21.7%) 5 (18.5%) 6 (26.1%)

        Severe asthma 6 (13.0%) 4 (14.8%) 3 (13.0%)

        Acute respiratory distress syndrome 2 (4.3%) 1 (3.7%) 1 (4.3%)

        Pulmonary hemorrhage 1 (2.2%) 0 (0.0%) 1 (4.3%)

        COPD 0 (0.0%) 0 (0.0%) 0 (0.0%)

    Infectious 13 (28.3%) 12 (44.4%) 3 (13.0%)

        Pneumonia or pulmonary sepsis 7 (15.2%) 6 (22.2%) 3 (13.0%)

        Bacterial infection (unspecified) 2 (4.3%) 2 (7.4%) 0 (0.0%)

    Hematological 2 (4.3%) 2 (7.4%) 0 (0.0%)

    Neurological 2 (4.3%) 2 (7.4%) 0 (0.0%)

    Endocrine 3 (6.5%) 3 (11.1%) 0 (0.0%)

    Other 3 (6.5%) 2 (7.4%) 1 (4.3%)

Indication for advanced respiratory supporta, n (%)

    Hypoxia 11 (40.7%) 15 (65.2%)

    CO2 retention 4 (14.8%) 0 (0.0%)

    Respiratory distress 2 (7.4%) 8 (34.8%)

    Respiratory arrest 8 (29.6%)

    Cardiac arrest 2 (7.4%)

    Airway protection 12 (44.4%)

    Airway obstruction 3 (11.1%)

    Other 1 (3.7%) 0 (0.0%)

COPD, chronic obstructive pulmonary disease. CO2, carbon dioxide.

a Multiple presumed diagnoses and indications for respiratory support could be selected for a patient.